<code id='EFBF35F0A5'></code><style id='EFBF35F0A5'></style>
    • <acronym id='EFBF35F0A5'></acronym>
      <center id='EFBF35F0A5'><center id='EFBF35F0A5'><tfoot id='EFBF35F0A5'></tfoot></center><abbr id='EFBF35F0A5'><dir id='EFBF35F0A5'><tfoot id='EFBF35F0A5'></tfoot><noframes id='EFBF35F0A5'>

    • <optgroup id='EFBF35F0A5'><strike id='EFBF35F0A5'><sup id='EFBF35F0A5'></sup></strike><code id='EFBF35F0A5'></code></optgroup>
        1. <b id='EFBF35F0A5'><label id='EFBF35F0A5'><select id='EFBF35F0A5'><dt id='EFBF35F0A5'><span id='EFBF35F0A5'></span></dt></select></label></b><u id='EFBF35F0A5'></u>
          <i id='EFBF35F0A5'><strike id='EFBF35F0A5'><tt id='EFBF35F0A5'><pre id='EFBF35F0A5'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:65
          A stethoscope lays on banknotes next to a calculator, all on top of a insurance application form — coverage from STAT
          Adobe

          Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report.

          But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there. They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

          advertisement

          Overall, private equity investors made only 4 investments in Medicare Advantage-related companies last year, compared with 12 in 2022, down from a peak of 19 in 2021, per the Private Equity Stakeholder Project, a group focused on holding private equity firms accountable for their impacts on people and the planet, according to its website.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          In diabetes hearing, Sanders takes on a new foe: food makers
          In diabetes hearing, Sanders takes on a new foe: food makers

          Sen.BerneSanders(I-Vt.)KevinDietsch/GettyImagesWASHINGTON—Sen.BernieSanders(I-Vt.)hasanewcorporateta

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

          3:30FILE-PeopleonbothsidesofthedebaterallyoutsidetheSupremeCourtinWashington,Monday,Dec.5,2022.Inade